In situ expression and significance of B7 costimulatory molecules within tissues of human gastric carcinoma

World Journal of Gastroenterology

Volumn 9, Issue 6, 2003, Pages 1370-1373

  Chen, Xiao Li ^a   Cao, Xu Dong ^b   Kang, An Jing ^a   Wang, Kang Min ^a   Su, Bao Shan ^a   Wang, Yi Li ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b SHIHEZI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; B7H1 ANTIGEN; B7H2 ANTIGEN; DIGOXIGENIN; INDUCIBLE COSTIMULATORY MOLECULE; INTERLEUKIN 10; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; METASTASIS; OLIGONUCLEOTIDE PROBE; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STAINING; STOMACH CARCINOMA; STOMACH ULCER; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR ESCAPE; TUMOR IMMUNITY;

EID: 0038389693     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i6.1370     Document Type: Article

References (36)

1. Ellis JH, Burden MN, Vinogradov DV, Linge C, Crowe JS. Interactions of CD80 and CD86 with CD28 and CTLA4. J Immunol 1996; 156: 2700-2709
2. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM. Pivotal role of the B7:CD28 pathway in trans-plantation tolerant and tumor immunity. Blood 1994; 84: 3261-3282
3. Ikemizu S, Gilbert RJ, Fennelly JA, Collins AV, Harlos K, Jones EY, Stuart DI, Davis SJ. Structure and dimerization of a soluble form of B7-1. Immunity 2000; 12: 51-60
4. + T cells in the antitumor immune response. J Exp Med 1998; 188: 2357-2368
5. Ganss R, Hanahan D. Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. Cancer Res 1998; 58: 4673-4681
6. Denfeld RW, Dietrich A, Wuttig C, Tanczos E, Weiss JM, Vanscheidt W, Schopf E, Simon JC. In situ expression of B7 and CD28 receptor families in human malignant melanoma: Relevance for T cell-mediated anti-tumor immunity. Int J Cancer 1995; 62: 259-265
7. Salvadori S, Martinelli G, Zier K. Resection of solid tumors reverses T cell defects and restores protective immunity. J Immunol 2000; 164: 2214-2220
8. Yu X, Fournier S, Allison JP, Sharpe AH, Hodes RJ. The role of B7 costimulation in CD4/CD8 T cell homeostasis. J Immunol 2000; 164: 3543-3553
9. Martin-Fontecha A, Moro M, Crosti MC, Veglia F, Casorati G, Dellabona P. Vaccination with mouse mammary adenocarcinoma cells coexpressing B7-1(CD80) and B7-2(CD86) discloses the dominant effect of B7-1 in the induction of antitumor immunity. J Immunol 2000; 164: 698-704
10. Kinoshita K, Tesch G, Schwarting A, Maron R, Sharpe AH, Kelley VR. Costimulation by B7-1 and B7-2 is repaired for autoimmune disease in MRL-Fas mice. J Immunol 2000; 164: 6046-6056
11. Geldhof AB, Raes G, Bakkus M, Devos S, Thielemans K, De Baetselier P. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res 1995; 55: 2730-2733
12. Huang M, Wang J, Lee P, Sharma S, Mao JT, Meissner H, Uyemura K, Modlin R, Wollman J, Dubinett SM. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 1995; 55: 3847-3853
13. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18: 263-266
14. Fujii H, Inobe M, Kimura F, Murata J, Murakami M, Onishi Y, Azuma I, Uede T, Saiki I. Vaccination of tumor cells transfected with the B7-1(CD80) gene induces the antimetastatic effect and tumor immunity in mice. Int J Cancer 1996; 66: 219-224
15. Wu TC, Huang AY, Jaffee EM, Levitsky HI, Pardoll DM. A reassessment of the role of B7-1 expression in tumor rejection. J Exp Med 1995; 182: 1415-1421
16. Judge TA, Tang A, Turka LA. Immunosupression through blockade of CD28:B7-mediated costimulatory signals. Immunol Res 1996; 15: 38-49
17. Hu JY, Wang S, Zhu JG, Zhou GH, Sun QB. Expression of B7 costimulation molecules by colorectal cancer cells reduces tumorigenicity and induces anti-tumor immunity. World J Gastroenterol 1999; 5: 147-151
18. Ren XF, Luo KX. Expression of B7 and liver diseases. Shijie Huaren Xiaohua Zazhi 1999; 7: 415-416
19. Guo J, Si L, Wang Y. An in situ study on immunostimulatory molecules in cancer cells within the cervical carcinoma tissues. Zhonghua Yixue Zazhi 2000; 80: 342-345
20. Song YJ, Yang ZY, Dong JH. Th1/Th2 cells and immune tolerance of transplantation. Shijie Huaren Xiaohua Zazhi 2001; 9: 794-796
21. Dong H, Zhu G, Tamada K, Chen L. B7H1, a third member of the B7 family, co-stimulates T cell proliferation and interleukin-10 secretion. Nat Med 1999; 5: 1365-1369
22. Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, Ni J, Chen L. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 2000; 96: 2808-2813
23. + T cells. J Immunol 2000; 165: 5035-5040
24. Dong C Juedes AE, Temann UA, Shresta S, Allison JP, Ruddle NH, Flavell RA. ICOS costimulatory receptor is essential for T-cell activation and function. Nature 2001; 409: 97-101
25. McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, Ling V, Freeman GJ, Sharpe AH. ICOS is critical for CD40-mediated antibody class switching. Nature 2001; 409: 102-105
26. Tafuri A, Shahinian A, Bladt F, Yoshinaga SK, Jordana M, Wakeham A, Boucher LM, Bouchard D, Chan VS, Duncan G, Odermatt B, Ho A, Itie A, Horan T, Whoriskey JS, Pawson T, Penninger JM, Ohashi PS, Mak TW. ICOS is essential for effective T-helper-cell responses. Nature 2001; 409: 105-109
27. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999; 397: 263-266
28. Liu X, Bai XF, Wen J, Gao JX, Liu J, Lu P, Wang Y, Zheng P, Liu Y. B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo. J Exp Med 2001; 194: 1339-1348
29. Guo J, Stolina M, Bready JV, Yin S, Horan T, Yoshinaga SK, Senaldi G. Stimulatory effects of B7-related protien-1 on cellular and humoral immune response in mice. J Immunol 2001; 166: 5578-5584
30. Riley JL, Blair PJ, Musser JT, Abe R, Tezuka K, Tsuji T, June CH. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement. J Immunol 2001; 166: 4943-4948
31. Yoshinaga SK, Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T, Shih G, Zhang M, Coccia MA, Kohno T, Tafuri-Bladt A, Brakow D, Campbell P, Chang D, Chiu L, Dai T, Duncan G, Elliott GS, Hui A, McCabe SM, Scully S, Shahinian A, Shaklee CL, Van G, Mak TW. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999; 402: 827-832
32. Tamatani T, Tezuka K, Hanzawa-Higuchi N. AILIM/ICOS: A novel lymphocyte adhesion molecule. Int Immunol 2000; 12: 51-55
33. Mages HW, Hutloff A, Heuck C, Buchner K, Himmelbauer H, Oliveri F, Kroczek RA. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur J Immunol 2000; 30L 1040-1047
34. Tamura H, Dong H, Zhu G, Sica GL, Flies DB, Tamada K, Chen L. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 2001; 97: 1809-1816
35. Beier KC, Hutloff A, Dittrich AM, Heuck C, Rauch A, Buchner K, Ludewig B, Ochs HD, Mages HW, Kroczek RA. Induction, binding specificity and function of human ICOS. Eur J Immunol 2000; 30: 3707-3717
36. Liu P, Si LS, Li R, Lai BC, Wang YL. Dynamic change of the local immune environment of human gastric carcinoma during the progress of this disease. Xi'an Yike Daxue Xuebao 2001; 22: 408-410